Synairgen (LSE:SNG) Deferred Tax : £0.00 Mil (TTM As of Jun. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Synairgen Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Synairgen's change in deferred tax for the six months ended in Jun. 2024 was £0.00 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Jun. 2024 was £0.00 Mil.

Synairgen Deferred Tax Historical Data

The historical data trend for Synairgen's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synairgen Deferred Tax Chart

Synairgen Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Deferred Tax

Get a 7-Day Free Trial

Synairgen Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Deferred Tax	Get a 7-Day Free Trial															-	-	-	-	-

Synairgen Deferred Tax Calculation

Deferred Tax for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.00 Mil.

Synairgen Deferred Tax Related Terms

Thank you for viewing the detailed overview of Synairgen's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

Synairgen Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Synairgen PLC (LSE:SNG) » Definitions » Deferred Tax

Comparable Companies

Traded in Other Exchanges

SYGGF:USA OMY:Germany

Address

Southampton General Hospital, Tremona Road, Mailpoint 810, Level F, South Block, Southampton, GBR, SO16 6YD

Website

https://www.synairgen.com

Synairgen PLC is a United Kingdom-based respiratory drug discovery and development company. The company is engaged in the drug discovery and development of therapies for respiratory diseases, particularly in areas, including severe asthma, kidney fibrosis, cardiac fibrosis, chronic obstructive pulmonary disease, and idiopathic pulmonary fibrosis. The company's Programmes include SNG001, SG016, SG018, and others.

Synairgen Headlines

No Headlines